Targeted Therapy and the Future of Lymphoma Treatment

Charles Gaulin, MBBS, an Assistant Professor of Medicine at Dartmouth Geisel School of Medicine, discussed the future of lymphoma treatment, including the development of novel cellular therapies and the reduction of chemotherapy.

“We’re much better at understanding disease biology and developing targeted approaches that are yielding similar to better efficacy in patients with lymphoma using non-traditional chemotherapy backbones,” Dr. Gaulin explained. “It’s a very exciting time for immune effector cell therapy development and targeted therapy approaches, which are going to really shape the future of lymphoma.”